• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从化脓性链球菌中分离出的细胞质膜相关蛋白(CAP):作为一种新型细菌超抗原。

Cytoplasmic membrane-associated protein (CAP) isolated from Streptococcus pyogenes: as a new bacterial superantigen.

作者信息

Sato H, Itoh T, Rikiishi H, Kumagai K

机构信息

Department of Microbiology, Tohoku University School of Dentistry, Sendai, Miyagi, Japan.

出版信息

Microbiol Immunol. 1994;38(2):139-47. doi: 10.1111/j.1348-0421.1994.tb01755.x.

DOI:10.1111/j.1348-0421.1994.tb01755.x
PMID:8041301
Abstract

A protein isolated from the cytoplasmic membranes of Streptococcus pyogenes (cytoplasmic membrane-associated protein, CAP) stimulated human T cells in vitro to induce their mitogenic response. This CAP-induced T cell proliferation required the presence of nylon-adherent accessory cells (AC) of either autologous or allogeneic origin in the reaction mixtures. In addition, the reaction was inhibited by monoclonal antibodies (mAbs) against major histocompatibility complex (MHC) class II molecules, HLA-DR and -DQ, but not -DP. Human lymphoid cell lines positive for HLA-DR but not those lacking it were also effective as AC for the reaction. A binding test using fluorescein-labeled protein revealed that CAP bound to the adherent monocytes and HLA-DR+ but not to -DR- lymphoid cell lines. The proliferative response of T cells to CAP was, however, not inhibited by the addition of the lysosomotrophic agent NH4Cl to the reaction mixtures. These results suggest that the presentation of CAP by AC to human T cells is mediated through binding of the protein to the MHC class II molecules but without being processed in the AC. The proliferative response of T cells was also found to be inhibited by addition of anti-CD2, -CD3 or -T cell receptor (TcR) mAbs. A major population responding to CAP was CD3+4+8- T cells. CAP also appears to stimulate T cells bearing V beta 8 sequences much more selectively than T cells bearing other V beta s. These results indicate that this streptococcal membrane protein, CAP, may be a new protein belonging to a group of bacterial superantigens.

摘要

从化脓性链球菌细胞质膜中分离出的一种蛋白质(细胞质膜相关蛋白,CAP)在体外刺激人T细胞,诱导其产生有丝分裂反应。这种CAP诱导的T细胞增殖需要反应混合物中存在自体或同种异体来源的尼龙黏附辅助细胞(AC)。此外,该反应受到针对主要组织相容性复合体(MHC)II类分子、HLA - DR和 - DQ但不包括 - DP 的单克隆抗体(mAb)的抑制。对HLA - DR呈阳性但缺乏该分子的人淋巴细胞系作为反应的AC也有效。使用荧光素标记蛋白的结合试验表明,CAP与黏附的单核细胞和HLA - DR + 结合,但不与 - DR - 淋巴细胞系结合。然而,向反应混合物中添加溶酶体营养剂NH4Cl并没有抑制T细胞对CAP的增殖反应。这些结果表明,AC将CAP呈递给人T细胞是通过该蛋白与MHC II类分子的结合介导的,但在AC中未被加工。还发现添加抗CD2、 - CD3或 - T细胞受体(TcR)mAb可抑制T细胞的增殖反应。对CAP作出反应的主要细胞群是CD3 + 4 + 8 - T细胞。与携带其他Vβ的T细胞相比,CAP似乎更有选择性地刺激携带Vβ8序列的T细胞。这些结果表明,这种链球菌膜蛋白CAP可能是属于一组细菌超抗原的新蛋白。

相似文献

1
Cytoplasmic membrane-associated protein (CAP) isolated from Streptococcus pyogenes: as a new bacterial superantigen.从化脓性链球菌中分离出的细胞质膜相关蛋白(CAP):作为一种新型细菌超抗原。
Microbiol Immunol. 1994;38(2):139-47. doi: 10.1111/j.1348-0421.1994.tb01755.x.
2
Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.从化脓性链球菌培养上清液中分离出的辅助性T细胞丝裂原(SPM-2)的超抗原性。
Immunology. 1997 Jul;91(3):406-13. doi: 10.1046/j.1365-2567.1997.00277.x.
3
Isolation of a new superantigen with potent mitogenic activity to murine T cells from Streptococcus pyogenes.从化脓性链球菌中分离出一种对小鼠T细胞具有强大促有丝分裂活性的新型超抗原。
FEMS Immunol Med Microbiol. 1996 Sep;15(2-3):81-91. doi: 10.1111/j.1574-695X.1996.tb00057.x.
4
Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).A群链球菌外毒素SpeF(MF)的超抗原特性
Infect Immun. 1994 Dec;62(12):5227-33. doi: 10.1128/iai.62.12.5227-5233.1994.
5
Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C.促有丝分裂因子(MF)作为一种新型链球菌超抗原的定义,该超抗原不同于链球菌致热外毒素A、B和C。
Eur J Immunol. 1996 Nov;26(11):2693-701. doi: 10.1002/eji.1830261122.
6
Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells.A 型链球菌致热外毒素对小鼠 T 细胞的激活作用。辅助细胞上 MHC Ⅱ类分子的需求以及毒素反应性 T 细胞 T 细胞受体中 Vβ元件的鉴定。
J Immunol. 1990 Nov 15;145(10):3170-6.
7
Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes.化脓性链球菌产生的化脓性链球菌热原性外毒素I和J(SPE-I和SPE-J)的免疫学和生化特性
J Immunol. 2001 Jun 1;166(11):6711-9. doi: 10.4049/jimmunol.166.11.6711.
8
Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.细菌超抗原以人类主要组织相容性复合体II类依赖的方式促进化脓性链球菌引起的急性鼻咽感染。
PLoS Pathog. 2014 May 29;10(5):e1004155. doi: 10.1371/journal.ppat.1004155. eCollection 2014 May.
9
A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.一种新型的不依赖HLA II类分子的TCR介导的T细胞激活机制,其特征在于增殖性寡克隆的Vβ特异性及其产生白细胞介素-2的能力。
Cell Immunol. 1996 Aug 1;171(2):200-10. doi: 10.1006/cimm.1996.0194.
10
Role of human major histocompatibility complex DQ molecules in superantigenicity of streptococcus-derived protein.人类主要组织相容性复合体DQ分子在链球菌衍生蛋白超抗原性中的作用。
Infect Immun. 1994 Apr;62(4):1228-35. doi: 10.1128/iai.62.4.1228-1235.1994.

引用本文的文献

1
Lipopolysaccharide-dependent down-regulation of CD27 expression on T cells activated with superantigen.脂多糖依赖的超抗原激活的T细胞上CD27表达的下调。
Immunology. 1999 Oct;98(2):289-95. doi: 10.1046/j.1365-2567.1999.00857.x.
2
Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.从化脓性链球菌培养上清液中分离出的辅助性T细胞丝裂原(SPM-2)的超抗原性。
Immunology. 1997 Jul;91(3):406-13. doi: 10.1046/j.1365-2567.1997.00277.x.
3
Superantigens and pseudosuperantigens of gram-positive cocci.
革兰氏阳性球菌的超抗原和假超抗原
Med Microbiol Immunol. 1995 May;184(1):1-8. doi: 10.1007/BF00216783.